How should we use anti-CTLA-4 antibodies?
Eur J Cancer
.
2015 Nov;51(17):2686-8.
doi: 10.1016/j.ejca.2015.09.002.
Authors
Aurélien Marabelle
1
,
Alexander Eggermont
2
Affiliations
1
Gustave Roussy Cancer Campus Grand Paris, 114 rue Edouard Vaillant, 94805 Villejuif, France; INSERM U1015, 94805 Villejuif, France.
2
Gustave Roussy Cancer Campus Grand Paris, 114 rue Edouard Vaillant, 94805 Villejuif, France.
PMID:
26613660
DOI:
10.1016/j.ejca.2015.09.002
No abstract available
Publication types
Comment
MeSH terms
Antibodies, Monoclonal / therapeutic use*
CTLA-4 Antigen / antagonists & inhibitors*
Female
Humans
Immunotherapy / methods*
Male
Melanoma / therapy*
Substances
Antibodies, Monoclonal
CTLA-4 Antigen